Olympic anti-doping lab puts U.S. meat supply to the test

Scientists at UCLA’s Olympic Analytical Laboratory turned their sophisticated analytical capabilities for testing athlete samples for performance-enhancing drugs to research examining the U.S. meat supply as part of a study led by Texas Tech. The study was designed to investigate concerns that residues of growth promoters used in meat production could potentially cause athletes to test positive.

Machine learning uncovers social risk clusters linked to suicide across the US

Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide. Scientists at Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons led the research that showed suicide rates vary significantly across the three clusters and that the patterns differ geographically across the United States.

Migraine drug can also help with symptoms that occur before the actual headache begins

A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three clinical trial published in Nature Medicine. The findings suggest that ubrogepant may be the first acute treatment for the symptoms that occur before migraine, which have a considerable impact on daily function.

US funding cuts have crippled our HIV work. What’s being lost?

The Trump administration’s cuts to funding for scientific research have left many scientists reeling and very worried. At the National Institutes of Health in the US, which has an annual budget of US$47 billion to support medical research both in the US and around the world, nearly 800 grants have been terminated. The administration is considering cutting the overall budget of the National Institutes of Health by 40%.